Avomeen Analytical Services: Carla Totton has been appointed the new leader of the company’s Quality Assurance Unit. She is responsible for developing, coordinating, implementing and monitoring the quality management system for all of Avomeen’s DEA, FDA and ISO 17025 compliant operations and facility.

“Carla brings a wealth of quality and regulatory expertise to Avomeen, having worked for contract labs in the analytical, development and manufacturing space,” said Mark Harvill, Avomeen chief executive officer. “Her blend of experience will further ensure we maintain a quality system and a culture of compliance consistent with global regulatory requirements.”

Ms. Totton is responsible for maintaining Avomeen’s compliance with regulatory requirements and standard operating procedures. The role includes working with regulatory authorities, conducting audits of the laboratory, manufacturing operations, work processes, and quality records, as well as managing accreditation applications and renewals. She also manages the controlled substance program, oversees the metrology and preventative maintenance program to ensure instruments and equipment are functioning properly, and monitors trends in order to improve major areas of the quality system.

Ms. Totton brings more than 10 years of experience from the pharmaceutical industry. Most recently, she worked for Catalent Pharma Solutions first as a senior regulatory compliance specialist and later as a product quality release specialist. Prior to this, she spent a year at Virbac US working as a Quality Auditor overseeing Quality Control. She also served as a Quality Assurance Supervisor for ABC Laboratories for seven years.